Half-year report · HY
7129.TEDINET S100X0ZA
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥23.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥193m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥125m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥197m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥645m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥200m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥168m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥300m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥12.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥13.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥13.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥503m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥174m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥117m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥456m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥217m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥588m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥853m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥425m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.03 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.95 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.61 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥49.93 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.05 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.14 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥509m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥477m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥514m |
| Childcaresupport Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥471m |
| Medicinereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥203m |
| Nursing Care Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥27m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥701m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥708m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥468m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥444m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥493m |
| Childcaresupport Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥364m |
| Medicinereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥266m |
| Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥618m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 545
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)青木 友紀 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都新宿区 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)山口 洋 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)愛知県名古屋市名東区 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)銭本 政己 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都新宿区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)ミアヘルサホールディングス株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都新宿区市谷仲之町３－１９ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Notes regarding financial covenant clauses (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Notes regarding impairment loss (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about assets for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about assets for each reportable segment (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |